Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube

Novaplex SARS-CoV-2 Variant assay mutations coverage table includes mutations consistent with Omicron, Stealth Omicron, Alpha, Beta, Gamma and Delta variants

The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron and its Stealth version. Published on: PR Newswire Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today unveiled another series of diagnostic test that detects the ever-changing COVID-19 variant landscape. The Novaplex™ SARS-CoV-2 Variants VII assay addresses Omicron and […]

Omicron Variant: Letter to our customers

To Our Valued Seegene Customer, The World Health Organization has identified the Omicron variant (B.1.1.529) as the latest strain of the SARS-CoV-2 virus to be designated as a Variant of Concern. As the first cases are emerging in the US, Seegene confirms that the performance or quality of the Seegene EUA Allplex™ 2019-nCoV Assay is […]

Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant

Published on: PR Newswire The Allplex™ SARS-CoV-2 Master Assay can simultaneously detect the wild-type coronavirus and the Omicron variant in a single test tube Seegene will support countries in need of diagnostics to help slow Omicron’s spread Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay is […]

Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC

Image shows Seegene's STARlet AIOS All in one solution for molecular testing for laboratories

Published on: PR Newswire Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in the Atlanta, GA, United States AIOS is the MDx system that integrates Seegene’s liquid handler and real-time PCR instruments. Seegene MDx system will efficiently access a wide array of Seegene’s syndromic assays. Seegene Inc. (KQ 096530), a […]

Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay

Published on: BUSINESS WIRE Real-time test differentiates influenza A & B, RSV and COVID-19 SEOUL, South Korea (March 1, 2021)— Seegene Inc., (KQ096530), a biotechnology company specializing in molecular diagnostics, has submitted its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay to the U.S. Food and Drug Administration for Emergency Use Authorization (EUA).  Seegene’s Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is a real-time […]

Seegene’s Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants

Published on: PR Newswire – Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min– Seegene’s proprietary high multiplex technology enables detection of 10 different targets– S. Korean firm to research additional versions of variant diagnostic tests Seegene (KQ096530), a biotechnology company specializing in molecular diagnostics, said Wednesday it […]

Seegene’s saliva test for COVID-19 is just as effective as NPS test

Published on: PR Newswire A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine, led by Professor In-bum Suh, carried out the PCR test for COVID-19 on […]